1. Dissociated Agonist of Glucocorticoid Receptor or Prednisone for Active Rheumatoid Arthritis: Effects on P1NP and Osteocalcin Pharmacodynamics. (27th May 2017) Authors: Shoji, S; Suzuki, A; Conrado, DJ; Peterson, MC; Hey‐Hadavi, J; McCabe, D; Rojo, R; Tammara, BK Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 6:Number 7(2017) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0496 Comparing tofacitinib safety profile in patients with psoriatic arthritis in clinical studies with real-world data. (15th June 2017) Authors: Curtis, JR; Yun, H; FitzGerald, O; Winthrop, K; Azevedo, VF; Burmester, G; Rigby, WFC; Kanik, KS; Rojo, R; Menon, S; Wang, C; Biswas, P; Hendrikx, T; Palmetto, N Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 676 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0439 Integrated safety summary of tofacitinib in psoriatic arthritis clinical studies. (15th June 2017) Authors: Burmester, G; FitzGerald, O; Winthrop, K; Williams, G; Azevedo, VF; Rigby, WFC; Kanik, K; Wang, C; Biswas, P; Jones, T; Menon, S; Palmetto, N; Rojo, R Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 938 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗